BASEL, Switzerland, March 31, 2022 /PRNewswire/ Luye Pharma Group (Luye Pharma) today announced that its subsidiary Luye Pharma Switzerland AG has entered into agreements with Exeltis Pharma
/PRNewswire/ Luye Pharma Switzerland AG ("Luye Switzerland"), a fully owned subsidiary of Luye Pharma Group (Luye Pharma), and Esteve Pharmaceuticals, S.A..
Italfarmaco Group Enters Into an Agreement with Luye Pharma to Commercialize Alzheimer s Disease Treatment Rivastigmine Multi-Day Transdermal Patch in Four European Countries finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.